Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.5K Buy
81
+34
+72% +$11.6K 0.02% 429
2026
Q1
$17K Sell
47
-34
-42% -$12.1K 0.01% 551
2025
Q4
$26.5K Buy
+81
New +$25.7K 0.02% 430

Other funds holding AMGN

Wellington-Altus USA's AMGN Position: Q2 2026 in Review

Wellington-Altus USA increased its Amgen (AMGN) stake by 72% in Q2 2026, buying an estimated $11.6K and bringing the position to 81 shares worth $28.5K. The position accounts for 0.02% of the portfolio, ranked #429.

Wellington-Altus USA first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wellington-Altus USA held 81 shares of Amgen worth $28.5K as of Q2 2026.
  • Wellington-Altus USA bought 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 0.02% of Wellington-Altus USA's portfolio in Q2 2026, its #429 holding.
  • Wellington-Altus USA first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wellington-Altus USA's 13F filing for Q2 2026, filed 17 Sep 2026.